WS
CL icon

Wedbush Securities’s Colgate-Palmolive CL Stock Holding History

Wedbush Securities’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
21,210
+3,758
+22% +$335K 0.05% 287
2025
Q4 		$1.38M Buy
17,452
+741
+4% +$58.1K 0.04% 340
2025
Q3 		$1.34M Buy
16,711
+480
+3% +$40.9K 0.04% 337
2025
Q2 		$1.48M Sell
16,231
-1,824
-10% -$167K 0.05% 300
2025
Q1 		$1.69M Sell
18,055
-127
-0.7% -$11.4K 0.06% 239
2024
Q4 		$1.65M Buy
18,182
+335
+2% +$32K 0.06% 236
2024
Q3 		$1.85M Buy
17,847
+589
+3% +$60K 0.07% 207
2024
Q2 		$1.68M Sell
17,258
-3,996
-19% -$369K 0.06% 234
2024
Q1 		$1.91M Buy
21,254
+3,599
+20% +$305K 0.07% 219
2023
Q4 		$1.41M Sell
17,655
-1,159
-6% -$87.1K 0.06% 243
2023
Q3 		$1.34M Sell
18,814
-388
-2% -$29K 0.07% 231
2023
Q2 		$1.48M Buy
19,202
+1,706
+10% +$132K 0.07% 219
2023
Q1 		$1.31M Buy
17,496
+162
+0.9% +$12K 0.07% 246
2022
Q4 		$1.37M Sell
17,334
-330
-2% -$24.7K 0.08% 225
2022
Q3 		$1.24M Buy
17,664
+9
+0.1% +$706 0.07% 229
2022
Q2 		$1.42M Buy
17,655
+174
+1% +$13.6K 0.08% 214
2022
Q1 		$1.33M Sell
17,481
-99
-0.6% -$7.84K 0.06% 268
2021
Q4 		$1.5M Sell
17,580
-1,092
-6% -$85.3K 0.06% 252
2021
Q3 		$1.41M Sell
18,672
-397
-2% -$31.5K 0.07% 266
2021
Q2 		$1.55M Buy
19,069
+522
+3% +$42.7K 0.07% 247
2021
Q1 		$1.46M Buy
18,547
+2,546
+16% +$200K 0.08% 229
2020
Q4 		$1.37M Sell
16,001
-4,876
-23% -$403K 0.12% 185
2020
Q3 		$1.61M Sell
20,877
-5,857
-22% -$447K 0.15% 141
2020
Q2 		$1.96M Sell
26,734
-2,725
-9% -$194K 0.19% 116
2020
Q1 		$1.96M Buy
29,459
+1,740
+6% +$123K 0.23% 99
2019
Q4 		$1.91M Sell
27,719
-83
-0.3% -$5.66K 0.17% 139
2019
Q3 		$2.04M Sell
27,802
-393
-1% -$28.5K 0.2% 114
2019
Q2 		$2.02M Sell
28,195
-284
-1% -$20.2K 0.2% 109
2019
Q1 		$1.95M Sell
28,479
-594
-2% -$38.4K 0.21% 112
2018
Q4 		$1.73M Buy
29,073
+3,535
+14% +$221K 0.22% 109
2018
Q3 		$1.71M Buy
25,538
+1,058
+4% +$70.5K 0.19% 114
2018
Q2 		$1.59M Buy
24,480
+2,158
+10% +$141K 0.2% 112
2018
Q1 		$1.6M Buy
22,322
+470
+2% +$33.8K 0.21% 112
2017
Q4 		$1.65M Sell
21,852
-720
-3% -$52.6K 0.2% 109
2017
Q3 		$1.64M Buy
22,572
+1,510
+7% +$109K 0.21% 96
2017
Q2 		$1.56M Buy
21,062
+1,431
+7% +$106K 0.2% 105
2017
Q1 		$1.44M Buy
19,631
+562
+3% +$39.3K 0.19% 109
2016
Q4 		$1.25M Buy
19,069
+3,443
+22% +$236K 0.18% 118
2016
Q3 		$1.16M Buy
15,626
+2,762
+21% +$204K 0.17% 129
2016
Q2 		$942K Buy
12,864
+1,877
+17% +$134K 0.15% 143
2016
Q1 		$776K Sell
10,987
-1,131
-9% -$75.2K 0.13% 165
2015
Q4 		$807K Buy
12,118
+466
+4% +$31K 0.15% 154
2015
Q3 		$739K Buy
11,652
+97
+0.8% +$6.34K 0.15% 161
2015
Q2 		$756K Buy
11,555
+2,593
+29% +$176K 0.14% 174
2015
Q1 		$621K Sell
8,962
-1,041
-10% -$72K 0.11% 219
2014
Q4 		$692K Buy
10,003
+1,519
+18% +$103K 0.11% 189
2014
Q3 		$553K Buy
8,484
+1,231
+17% +$81.2K 0.09% 238
2014
Q2 		$495K Buy
7,253
+1,418
+24% +$95K 0.08% 263
2014
Q1 		$379K Sell
5,835
-405
-6% -$25.5K 0.07% 302
2013
Q4 		$407K Buy
6,240
+492
+9% +$31.5K 0.1% 252
2013
Q3 		$341K Sell
5,748
-527
-8% -$31.2K 0.09% 261
2013
Q2 		$359K Buy
+6,275
New +$372K 0.1% 248

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wedbush Securities's CL Position: Q1 2026 in Review

Wedbush Securities increased its Colgate-Palmolive (CL) stake by 22% in Q1 2026, buying an estimated $335K and bringing the position to 21,210 shares worth $1.81M. The position accounts for 0.05% of the portfolio, ranked #287.

Wedbush Securities first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.04M in Q3 2019. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Wedbush Securities held 21,210 shares of Colgate-Palmolive worth $1.81M as of Q1 2026.
  • Wedbush Securities bought 3,758 Colgate-Palmolive shares in Q1 2026, an estimated $335K.
  • Colgate-Palmolive made up 0.05% of Wedbush Securities's portfolio in Q1 2026, its #287 holding.
  • Wedbush Securities first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Wedbush Securities's Colgate-Palmolive position peaked at $2.04M in Q3 2019.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.